No Data
B-SOFTLtd (SZSE:300451 Shareholders Incur Further Losses as Stock Declines 7.2% This Week, Taking Five-year Losses to 45%
GF SEC: The recovery of Medical IT Orders in February, pay attention to the subsequent implementation of AI Orders.
With the continuous deepening of AI technology applications and the increasingly sound Medical data security and compliance framework, it is expected that the demand for Medical IT will steadily rise in the next 3-5 years.
B-SOFTLtd (SZSE:300451) Will Want To Turn Around Its Return Trends
B-Soft Co., Ltd. (300451.SZ): Currently, the BsoftGPT platform has integrated mature model APIs from the market, including DeepSeek and Qwen - Max.
On March 4th, Gluon Hong reported that B-Soft Co.,Ltd. (300451.SZ) stated on the investor interaction platform that the company is actively promoting the integration of AI with Business to empower Medical scenarios. It hopes to initiate a new paradigm of "AI + Medical". Currently, AI product services such as CDSS and intelligent medical assistants have been provided, while also vigorously developing new products like MedCopilot and APTS. In the application of large models, the company continues to focus on the fields of large models + Medical, and its own BsoftGPT platform can connect to third-party knowledge bases and large models; currently, the BsoftGPT platform has connected to include.
Minsheng Securities: The commercial value of AI Medical is gradually being released, driven by both policy and capital.
The development of AI in the Medical Industry has become an inevitable trend.
B-SOFT Director Plans to Sell Up to 6 Million Shares
B-SOFTLtd (SZSE:300451 Shareholders Incur Further Losses as Stock Declines 5.6% This Week, Taking One-year Losses to 54%
